Skip to content
Screener

Grace Therapeutics, Inc. GRCE Q2 2026 earnings

Reported August 13, 2026 · Before market open

EPS-$0.91Miss by $0.78
Revenue estimate$400.0K
EPS estimate-$0.13

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.0M
EPS estimate-$0.15

FAQ

When did Grace Therapeutics, Inc. report Q2 2026 earnings?
Grace Therapeutics, Inc. (GRCE) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Grace Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Grace Therapeutics, Inc. reported eps of $-0.91 for Q2 2026.
Did Grace Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.13 by $0.78.
How did Grace Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 333.3% from $-0.21.
Where can I find Grace Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001140361-26-032644) and the 10-Q periodic report (0001140361-26-032632) directly on SEC EDGAR. The filing index links above go to sec.gov.